The proposed bill, known as the Chemical Abortion Safety Protocol Act, aims to establish specific protocols and requirements for the provision of abortion-inducing drugs in Nebraska. It introduces definitions for key terms such as "abortion-inducing drug" and "adverse event," and mandates that physicians must conduct an in-person examination of the woman, verify her pregnancy, and assess for ectopic pregnancies before providing such drugs. Additionally, the bill requires physicians to schedule a follow-up visit within a specified timeframe to confirm the termination of pregnancy and document any adverse events that may arise.

Furthermore, the bill amends existing law by adding a new provision that classifies violations of the Chemical Abortion Safety Protocol Act as unprofessional conduct for physicians. It also includes a severability clause to ensure that if any part of the act is deemed invalid, the remaining sections will still be enforceable. The original section of the law that is being amended is repealed, and the bill emphasizes that women who undergo an abortion will not be held liable for any violations of this act.

Statutes affected:
Introduced: 38-2021